Check out this case study to see the great outcome of a basal cell carcinoma patient thanks to treatment with the RADiant system. See the full case study below.
RADiant Treatment Case Study: Basal Cell Carcinoma
read more
Clinical Systems
Xstrahl in Action: Xstrahl 150 used in study on Arthroses on Dogs
Radiation therapy in benign diseases, particularly in arthroses, has been used as a successful treatment method in human medicine for more than one hundred years. In their study “Röntgenreizbestrahlungen bei 60 Hunden mit Osteoarthrosen” A.-Ch. Voss & I....
Xstrahl in Action: Xstrahl 200 used in study into pituitary tumors in animals
In their study “Effektivität der Strahlentherapie in der Behandlung von hypophysären Tumoren bei 13 Hunden” Simona Mayer-Stankeová , Carla Rohrer Bley , Melanie Wergin , Nadja Sieber-Ruckstuhl , Monique Wenger , Malgorzata Roos , Claudia Reusch , Andrea Sumová &...
RADiant to Exhibit at the 2019 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL...
Xstrahl 150 Used as System of Choice for Australian Case Study Reviews
With the rates of skin cancers ever increasing, especially in places with high sun prevalence, treatment of these conditions can cause not only a demand on resources, but there is a lack of unified response and the best way to treat. This is why Prof. Gerald Fogarty...
Xstrahl Spotlights New RADiant Treatment System at CalDerm 2019
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual California Society of Dermatology symposium in Santa Barbara from September...
Xstrahl in Action: Xstrahl 200 Used for Research into Clinical Response Following Superficial Radiation Therapy of SCCs
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and arises from abnormal growth in the squamous cells of the skin’s outermost layer due to cumulative exposure to ultraviolet radiation. Without treatment, cSCC can be...
Xstrahl in Action: Xstrahl 200 Used for Tissue Conservation and Long-Term Control of Melanoma
In their paper “Xstrahl therapy results in tissue conservation and long-term control of melanoma in situ of the lower eyelid” Gerald B Fogarty, Amy Ziebell, Stephanie Nicholls, Susith Kulasekara, Doug Duthie and Krishna Tumuluri present the case of a middle-aged woman...
RADiant Treatments Commence at Leading Texas Dermatology Center
A leading San Antonio dermatology center has become the first in Texas to commence advanced skin cancer radiotherapy treatments using the new RADiant treatment system from Xstrahl, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and...
Contact Us